CHARLES SCHWAB INVESTMENT MANAGEMENT INC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$856,316
-61.1%
217,339
+5.1%
0.00%
-100.0%
Q2 2023$2,199,251
+61.3%
206,891
+26.4%
0.00%
Q1 2023$1,363,746
-10.4%
163,715
-0.7%
0.00%
Q4 2022$1,521,676
-27.0%
164,862
+1.6%
0.00%
-100.0%
Q3 2022$2,084,000
-4.8%
162,245
-2.0%
0.00%0.0%
Q2 2022$2,188,000
-31.0%
165,620
+9.9%
0.00%0.0%
Q1 2022$3,173,000
-10.5%
150,732
+2.0%
0.00%0.0%
Q4 2021$3,546,000
-4.5%
147,780
+1.2%
0.00%0.0%
Q3 2021$3,715,000
-19.2%
145,997
+6.9%
0.00%
-50.0%
Q2 2021$4,599,000
-3.2%
136,622
+11.7%
0.00%0.0%
Q1 2021$4,753,000
-33.8%
122,360
+5.5%
0.00%
-33.3%
Q4 2020$7,184,000
+128.8%
115,997
+23.7%
0.00%
+200.0%
Q3 2020$3,140,000
+106.2%
93,759
+46.7%
0.00%0.0%
Q2 2020$1,523,000
-5.6%
63,891
-9.2%
0.00%0.0%
Q1 2020$1,613,000
+7.6%
70,403
+33.1%
0.00%0.0%
Q4 2019$1,499,000
+33.1%
52,900
+1.0%
0.00%0.0%
Q3 2019$1,126,00052,3540.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$562,187,00075.80%
RTW INVESTMENTS, LP 3,544,248$118,697,0002.86%
Cormorant Asset Management, LP 1,537,807$51,501,0001.98%
Redmile Group, LLC 2,549,506$85,383,0001.57%
Birchview Capital, LP 40,000$1,340,0000.45%
HighVista Strategies LLC 17,082$572,0000.42%
Perceptive Advisors 671,978$22,505,0000.33%
GILDER GAGNON HOWE & CO LLC 1,490,153$49,905,0000.31%
Artal Group S.A. 270,750$9,067,0000.22%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 323$11,0000.20%
View complete list of STOKE THERAPEUTICS INC shareholders